VANCOUVER, BRITISH COLUMBIA--(Marketwire - January 10, 2008) - Inflazyme Pharmaceuticals Ltd., (NEX: IZP.H) announced today that effective January 1, 2008, Michael Liggett was appointed as a director of the Company. The Board has also appointed Michael as acting CEO and President effective January 1, 2008.
